Targeted Degradation of KRASG12D as Potential Therapy in Cancer.
Sign Up to like & getrecommendations! Published in 2023 at "ACS medicinal chemistry letters"
DOI: 10.1021/acsmedchemlett.3c00111
Abstract: Selective proteolysis represents a cutting-edge therapeutic approach that is garnering global interest due to its capacity to eradicate pathogenic biomolecules within cellular environments. For instance, the PROTAC technology brings the ubiquitin proteasome system degradation machinery… read more here.
Keywords: potential therapy; therapy cancer; krasg12d potential; targeted degradation ... See more keywords